Physician profile
Jill E Placek
NPI 1831477843
$1,799.17
in general payments reported to CMS, 2019-2025
29 companies · $21.96 in 2025
The $21.96 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $77.71 · 2021: $18.27 · 2022: $100 · 2023: $523 · 2024: $559 · 2025: $21.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,104.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $391.13 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $169.50 | 2023-2024 | Myfembree |
| Hologic Sales and Service, LLC | $145.99 | 2019-2025 | Thinprep 2000 Processor, Aptima, Coolseal Generator |
| Astellas Pharma US INC | $131.69 | 2023-2024 | Veozah |
| Coopersurgical, INC. | $105.34 | 2019-2024 | Paragard T 380a, Paragard T 380a, Summit Doppler |
| Amgen INC. | $96.74 | 2019-2023 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $90.21 | 2022-2024 | |
| Gynesonics, INC. | $65.02 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mayne Pharma Commercial LLC | $64.44 | 2024 | |
| Merck Sharp & Dohme LLC | $63.13 | 2023-2024 | Gardasil 9, Gardasil |
| Roche Diagnostics Corporation | $58.29 | 2019 | |
| Pfizer INC. | $57.18 | 2023-2024 | |
| Exact Sciences Corporation | $46.34 | 2023-2024 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $38.49 | 2019 | |
| Dysis Medical, INC. | $38.16 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $35.61 | 2024 | Slynd |
| Davol INC. | $24.52 | 2019 | |
| Organon LLC | $21.82 | 2023 | Nexplanon |
| Avion Pharmaceuticals | $19.36 | 2023 | Balcoltra |
| Hologic INC | $18.27 | 2021 | |
| Amag Pharmaceuticals, INC. | $17.22 | 2019 | |
| Acessa Health INC. | $15.19 | 2020 | |
| Vertical Pharmaceuticals, LLC | $13.75 | 2019 | |
| Allergan, INC. | $13.51 | 2019 | |
| Duchesnay USA Incorporated | $12.69 | 2019 | |
| Boston Scientific Corporation | $12.64 | 2019 | |
| Mission Pharmacal Company | $11.99 | 2019 | |
| Covidien LP | $10.91 | 2019 | |
| Monaghan Medical Corporation | $10.04 | 2023 | Aeroeclipse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Placek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.